Susquehanna International Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-241,100
Closed -$9.95M 10869
2015
Q2
$9.95M Buy
241,100
+214,500
+806% +$7.69M ﹤0.01% 2009
2015
Q1
$937K Sell
26,600
-84,200
-76% -$2.85M ﹤0.01% 5891
2014
Q4
$3.56M Sell
110,800
-191,600
-63% -$5.54M ﹤0.01% 3435
2014
Q3
$8.48M Buy
302,400
+130,300
+76% +$3.97M ﹤0.01% 2292
2014
Q2
$5.2M Buy
172,100
+117,200
+213% +$3.24M ﹤0.01% 3010
2014
Q1
$1.52M Sell
54,900
-5,100
-9% -$133K ﹤0.01% 4780
2013
Q4
$1.53M Buy
60,000
+12,400
+26% +$382K ﹤0.01% 4732
2013
Q3
$1.42M Sell
47,600
-17,000
-26% -$473K ﹤0.01% 4699
2013
Q2
$1.86M Buy
+64,600
New +$1.78M ﹤0.01% 4022

Other funds holding BRLI

Susquehanna International Group's BRLI Position: Q3 2015 in Review

Susquehanna International Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 41,817 shares — an estimated $1.73M sold.

Susquehanna International Group first reported a position in BRLI in Q4 2013 and held it in 6 quarters. The position peaked at $5.17M in Q2 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Susquehanna International Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Susquehanna International Group sold 41,817 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.73M.
  • Susquehanna International Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's BIO-REFERENCE LABS INC-NEW- position peaked at $5.17M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.